Clinical Trial Update: The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dexamethasone alone to dexamethasone plus rituximab in newly diagnosed idiopathic thrombocytopenic purpura (ITP) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Rituximab (rituximab)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED